Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.
Tianjin Key Laboratory of Urban Transport Emission Research, College of Environmental Science and Engineering, Nankai University, Tianjin, 300071, China.
Biomaterials. 2022 Dec;291:121901. doi: 10.1016/j.biomaterials.2022.121901. Epub 2022 Nov 4.
Diabetes has been associated with postoperative complications, such as increased risk of tissue infection and impaired tissue repair caused by destabilization of hypoxia-inducible factor-1α (HIF-1α). Consequently, it is imperative to fabricate anti-bacterial and pro-regenerative small-diameter vascular grafts for treating cardiovascular disease in diabetic patients. Herein, we developed electrospun cobalt ion (Co)-loaded poly (ε-caprolactone) (PCL) microfiber vascular grafts (PCL-Co grafts). The released Co significantly increased the stabilization of HIF-1α in high-glucose (HG)-treated HUVECs (HG-HUVECs) and macrophages (HG-macrophages). This resulted in enhanced cell migration, nitric oxide production, and secretion of bioactive factors by HG-HUVECs, and polarization of HG-macrophages toward M2 phenotypes in vitro. The Co also conferred anti-bacterial properties to the grafts, while not perturbing the inherent anti-bacterial activities of HG-macrophages. Following abdominal artery implantation into type 2 diabetes mellitus (T2DM) rats, PCL-Co grafts were evaluated for performance in infection (grafts pre-contaminated with Staphylococcus aureus) and prophylaxes models (grafts alone). PCL-Co grafts prevented the incidence of subsequent infection in prophylaxes model and effectively inhibited the bacterial growth in the infection model. PCL-Co grafts also significantly enhanced cellularization, vascularization, endothelialization, contractile SMC regeneration and macrophages polarization in both models. Collectively, PCL-Co grafts exhibited the potential to combat infection and improve tissue regeneration under diabetes conditions.
糖尿病与术后并发症有关,例如组织感染风险增加和缺氧诱导因子-1α(HIF-1α)失稳导致组织修复受损。因此,为了治疗糖尿病患者的心血管疾病,迫切需要制造具有抗菌和促进再生功能的小直径血管移植物。在此,我们开发了负载钴离子(Co)的静电纺聚己内酯(PCL)微纤维血管移植物(PCL-Co 移植物)。释放的 Co 显著增加了高葡萄糖(HG)处理的人脐静脉内皮细胞(HG-HUVECs)和巨噬细胞(HG-巨噬细胞)中 HIF-1α的稳定性。这导致 HG-HUVECs 细胞迁移、一氧化氮产生和生物活性因子分泌增强,以及 HG-巨噬细胞向 M2 表型极化。Co 还赋予移植物抗菌性能,而不干扰 HG-巨噬细胞固有的抗菌活性。将 PCL-Co 移植物植入 2 型糖尿病(T2DM)大鼠的腹主动脉后,在感染(移植物预先用金黄色葡萄球菌污染)和预防模型(单独移植物)中评估其性能。PCL-Co 移植物在预防模型中防止了随后感染的发生,并在感染模型中有效抑制了细菌生长。PCL-Co 移植物还显著增强了两种模型中的细胞化、血管生成、内皮化、收缩性平滑肌细胞再生和巨噬细胞极化。总之,PCL-Co 移植物具有在糖尿病条件下抵抗感染和促进组织再生的潜力。